AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
5.05
+0.15 (3.06%)
At close: Sep 18, 2026, 4:00 PM EDT
5.04
-0.01 (-0.20%)
After-hours: Sep 18, 2026, 7:30 PM EDT
AN2 Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Selling, General & Admin | 2.89 | 3.81 | 2.44 | 3.04 | 4.02 | 3.85 | 3.21 | 3.48 | 3.73 | 3.64 | 3.9 | 3.75 | 3.06 | 4.05 | 3.72 | 3.34 | 3.64 | 2.05 | 1.78 | 1.59 |
Research & Development | 6.02 | 6.74 | 6.88 | 7 | 3.2 | 7.69 | 5.4 | 8.29 | 12.15 | 14.66 | 14.92 | 14.43 | 13.54 | 11.99 | 8.75 | 8.43 | 6.7 | 5.63 | 5.81 | 5.35 |
Operating Expenses | 8.9 | 10.55 | 9.32 | 10.04 | 7.22 | 11.54 | 8.61 | 11.77 | 15.88 | 18.3 | 18.82 | 18.18 | 16.6 | 16.04 | 12.48 | 11.77 | 10.33 | 7.68 | 7.59 | 6.93 |
Operating Income | -8.9 | -10.55 | -9.32 | -10.04 | -7.22 | -11.54 | -8.61 | -11.77 | -15.88 | -18.3 | -18.82 | -18.18 | -16.6 | -16.04 | -12.48 | -11.77 | -10.33 | -7.68 | -7.59 | -6.93 |
Interest & Investment Income | 0.72 | 0.52 | 0.61 | 0.69 | 0.75 | 0.89 | 1.08 | 1.27 | 1.45 | 1.68 | 4.86 | - | - | - | - | - | - | - | 0.03 | 0.03 |
Currency Exchange Gain (Loss) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.02 | -0.04 |
Other Non Operating Income (Expenses) | -0 | - | 0 | - | - | - | - | - | - | 0 | -2.94 | 1.47 | 0.8 | 0.72 | 0.63 | 0.43 | 0.21 | 0.03 | - | - |
EBT Excluding Unusual Items | -8.19 | -10.03 | -8.71 | -9.35 | -6.46 | -10.65 | -7.53 | -10.5 | -14.44 | -16.62 | -16.9 | -16.71 | -15.8 | -15.32 | -11.84 | -11.34 | -10.12 | -7.66 | -7.55 | -6.94 |
Merger & Restructuring Charges | - | - | - | - | - | - | 0.01 | -2.24 | - | - | - | - | - | - | - | - | - | - | - | - |
Pretax Income | -8.19 | -10.03 | -8.71 | -9.35 | -6.46 | -10.65 | -7.52 | -12.75 | -14.44 | -16.62 | -16.9 | -16.71 | -15.8 | -15.32 | -11.84 | -11.34 | -10.12 | -7.66 | -7.55 | -6.94 |
Net Income | -8.19 | -10.03 | -8.71 | -9.35 | -6.46 | -10.65 | -7.52 | -12.75 | -14.44 | -16.62 | -16.9 | -16.71 | -15.8 | -15.32 | -11.84 | -11.34 | -10.12 | -7.66 | -7.55 | -6.94 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.82 | 1.93 | 1.93 |
Net Income to Common | -8.19 | -10.03 | -8.71 | -9.35 | -6.46 | -10.65 | -7.52 | -12.75 | -14.44 | -16.62 | -16.9 | -16.71 | -15.8 | -15.32 | -11.84 | -11.34 | -10.12 | -9.48 | -9.47 | -8.87 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 45 | 34 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 26 | 19 | 19 | 19 | 19 | 19 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 45 | 34 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 26 | 19 | 19 | 19 | 19 | 19 | 3 | 3 | 3 |
Shares Change (YoY) | 48.35% | 13.33% | 1.58% | 1.46% | 1.17% | 0.98% | 0.50% | 16.36% | 52.97% | 53.53% | 53.65% | 32.55% | 1.24% | 509.47% | 629.19% | 631.77% | 631.15% | 21.37% | - | - |
EPS (Basic) | -0.18 | -0.29 | -0.29 | -0.31 | -0.21 | -0.35 | -0.25 | -0.43 | -0.48 | -0.56 | -0.57 | -0.65 | -0.81 | -0.79 | -0.61 | -0.59 | -0.53 | -2.98 | -3.57 | -3.35 |
EPS (Diluted) | -0.18 | -0.29 | -0.29 | -0.31 | -0.21 | -0.35 | -0.25 | -0.43 | -0.48 | -0.56 | -0.57 | -0.65 | -0.81 | -0.79 | -0.61 | -0.59 | -0.53 | -2.98 | -3.57 | -3.35 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
EBIT | -8.9 | -10.55 | -9.32 | -10.04 | -7.22 | -11.54 | -8.61 | -11.77 | -15.88 | -18.3 | -18.82 | -18.18 | -16.6 | -16.04 | -12.48 | -11.77 | -10.33 | -7.68 | -7.59 | -6.93 |